The effect of sage (Salvizan gel) compared to triamcinolone acetonide on the treatment of recurrent aphthous stomatitis: a double-blinded randomized clinical trial.

Abstract

BACKGROUND:

Recurrent Aphthous Stomatitis (RAS) is one of the most common lesions of the oral mucosa. Herbal medicine can be used for the treatment of this disease. The present study aimed to compare the effects of topical application of Sage (Salvizan) and triamcinolone acetonide gels on RAS.

METHODS:

This double-blind clinical study recruited sixty patients with minor aphthous ulcers. Half of the patients were treated with Salvizan gel, and the other half were treated with oral triamcinolone acetonide gel. The effect of Salvizan topical gel was evaluated and compared with that of oral triamcinolone acetonide gel. Factors such as Pain recovery time, wound healing time, and pain level was evaluated. Data were analyzed by SPSS version 22 using independent t-test, paired t-test, repeated measures ANOVA, and survival analysis, including Kaplan-Meier and Cox regression.

RESULTS:

The mean duration of pain recovery was 1.5 days for Salvizan and 2.5 days for triamcinolone acetonide (p < 0.001). Moreover, the duration of wound healing was 3.3 days for Salvizan and 6 days for triamcinolone acetonide (p < 0.001). Patients' satisfaction from factors such as taste and smell had no significant difference between the two groups.

CONCLUSION:

The results of this study showed that Salvizan gel is very effective in the treatment of RAS. It was significantly better than triamcinolone acetonide in the pain recovery and wound healing. These promising results favor herbal treatments and show that they can be used more commonly for treating diseases such as RAS.

TRIAL REGISTRATION:

This study was approved by the ethics committee of Isfahan University of Medical Sciences (IR.MUI.

RESEARCH:

REC.1399.834) on 17/03/2021. It was also registered in the Iranian Registry of Clinical Trials (IRCT20100202003251N7).

• Authors: Fatemeh Abbasi, Zeinab Rasoulzadeh, Amirmohammad Yavari
• Journal: BMC oral health (BMC Oral Health) Vol. 23 Issue 1 Pg. 157 (03 18 2023) ISSN: 1472-6831 [Electronic] England
• PMID: 36934268 (Publication Type: Randomized Controlled Trial, Journal Article, Research Support, Non-U.S. Gov't)
• Copyright: © 2023. The Author(s).

Chemical References

• Triamcinolone Acetonide
• Gels

Topics

• Humans
• Triamcinolone Acetonide (therapeutic use, adverse effects)
• Stomatitis, Aphthous (drug therapy)
• Iran
• Gels (therapeutic use)
• Pain